Skip to main content
. 2013 Aug;2(4):273–283. doi: 10.3978/j.issn.2218-6751.2013.03.12

Table 3. Selected molecular targets with potential therapeutic agents.

Gene Drugs References
EGFR Cetuximab, erlotinib, gefitinib, afatinib, dacomitinib (93)
ERBB2 Afatinib, dacomitinib, lapatinib (93)
N-cadherin ADH-1 (94)
VEGFR1 Vandetanib, sorafenib, sunitinib, axitinib, cabozantinib, pazopanib (95)
CX3CR1 F1 hCX3CL1 analog (96)
MET Onartuzumab, tivantinib (93)
CXCR4 Plerixafor (95)